Table 2.
Demographic and neuropsychological information for Parkinson's disease High Low Fatigue.
| Parkinson's disease High (n = 29) |
Parkinson's disease Low (n = 31) |
P-value | |
|---|---|---|---|
| Male:Female | 24:5 | 19:12 | 0.065 |
| Age (years) | 67.00 ± 6.02 | 68.10 ± 5.06 | 0.447 |
| Education (years) | 16.10 ± 2.88 | 16.68 ± 2.76 | 0.434 |
| Sleep Duration | 6.96 ± 1.09 | 6.75 ± 1.41 | 0.529 |
| Levodopa Equivalency | 626.63 ± 372.17 | 524.10 ± 307.13 | 0.256 |
| Unified Parkinson Disease Rating Scale-IIIb | 20.67 ± 10.63 | 16.20 ± 8.47 | 0.157 |
| Disease duration (years) | 8.72 ± 5.68 | 6.32 ± 4.94 | 0.085 |
| Mini-Mental State Examinationa | 28.55 ± 1.15 | 28.58 ± 1.46 | 0.933 |
| BDI II | 11.14 ± 5.97 | 6.32 ± 4.40 | 0.001 |
| Fatigue Severity Scale | 43.64 ± 8.60 | 23.77 ± 6.76 | 0.000 |
| Leukoariosis | 2762.56 ± 4004.63 | 4949.72 ± 5730.06 | 0.098 |
| total intracranial volume | 1710059 ± 158,270 | 1668833 ± 15834 | 0.318 |
| Leukoariosis/total intracranial volume | 0.002 ± 0.002 | 0.003 ± 0.003 | 0.072 |
a
On medication.
b
Raw voxel volume.